Aug 2026· ACS Applied Bio Materials· Vol 9, pp. 8169-8183· 0 citations· 68 references
Medicine
TL;DR
The efficacy of synthesized lysine- and histidine-containing two self-assembled amphiphilic cationic peptides as nanomedicine against multidrug-resistant clinically isolated bacterial strains indicates that the assembled peptide nanostructures can serve as an effective scaffold in drug design, combating antimicrobial resistance with sustainable applications in nanomedicine-based therapeutics.
Abstract
We herein explore the efficacy of synthesized lysine- and histidine-containing two self-assembled amphiphilic cationic peptides (SAACPs) as nanomedicine against multidrug-resistant clinically isolated bacterial strains. These SAACPs are self-assembled in water (pH 6.9) to form nanospheres with potent antibacterial activities. FEG-TEM and atomic force microscopy studies revealed the nanospherical and nanofibrillar structure. Detailed mechanistic studies probing the antibacterial activities of these self-assembled peptides substantiated that they have high efficacy to kill both Gram-positive and Gram-negative bacterial cells by permeabilizing the bacterial membranes. They exhibited potential antibacterial activity against a wide range of pathogenic non-virulent strains and clinically isolated multidrug-resistant ATCC bacterial strains. These peptide nanostructures, in particular, function as potent antibiotic sensitizers, increasing the efficacy of meropenem and reducing the minimal dosages required to stop clinical isolates that are resistant to it. MTT assay studies revealed the non-cytotoxicity of these peptides with IC50 values above 2.5 mg/mL against human embryonic kidney (HEK-293) cell lines, which is much higher than the dose for bactericidal activity of these self-assembled peptides. This indicates that the assembled peptide nanostructures can serve as an effective scaffold in drug design, combating antimicrobial resistance with sustainable applications in nanomedicine-based therapeutics.
Interestingly, this injectable hydrogel also displayed strong antibiofilm performance against bacterial strains like methicillin-resistant Staphylococcus aureus and Klebsiella pneumoniae and also against fungal pathogens such as Aspergillus niger and fluconazole-resistant Candida albicans.
Supratim Bose, Sayani Haldar, Bikram Das et al.· ACS Applied Bio Materials· 0 citations
The rapid progress of multidrug‐resistant (MDR) bacterial infections and the clinical aggressiveness of triple‐negative breast cancer (TNBC) possess a great problem to human beings. It necessitates the discovery and development of multifunctional therapeutic biomaterials. Herein, we report two enzymatically stable shor...
Supratim Bose, Ananya Das, Swapnendu Deb et al.· ChemBioChem· 0 citations
Enhanced therapeutic potential for scorpion-derived AMP analogs-loaded PLGA nanoparticles is demonstrated, providing a dual antimicrobial and anti-inflammatory strategy for severe infections such as sepsis, and support further development of AMP-based nanomedicines.
Bruno Amorim-Carmo, Emanuell Santos-Silva, Alessandra Daniele-Silva et al.· Biomedicine & pharmacotherap...· 0 citations
The presented results suggest that Janus nanoparticles can be designed using conventional biochemicals/chemicals with poor antibacterial properties and can be used for broad-spectrum antibacterial applications.
Puja Garai, Tanushree Mondal, Swapnendu Deb et al.· ACS Applied Nano Materials· 0 citations
Antimicrobial resistance (AMR) and biofilm-associated infections create a need for locally active biomaterials that can combine bacterial killing with tissue compatibility and controlled antimicrobial exposure. Pristine nanocellulose has limited intrinsic antibacterial activity; therefore, its biomedical value depends...
It is demonstrated that coordination-driven self-assembly of natural flavonoids and biocompatible metal ions represents a potential strategy for developing antimicrobial materials against drug-resistant staphylococcal infections.
Ying Chen, Xiu-Zhen Chen, Wei-Xiao Wang et al.· Frontiers in Microbiology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.